Aliases & Classifications for Cerebral Aneurysms

MalaCards integrated aliases for Cerebral Aneurysms:

Name: Cerebral Aneurysms 50
Cerebral Aneurysm 28 51 69
Cerebral Arterial Aneurysm 69

External Ids:

Summaries for Cerebral Aneurysms

NINDS : 50 A cerebral aneurysm is a weak or thin spot on a blood vessel in the brain that balloons out and fills with blood.  An aneurysm can press on a nerve or surrounding tissue, and also leak or burst, which lets blood spill into surrounding tissues (called a hemorrhage). Cerebral aneurysms can occur at any age, although they are more common in adults than in children and are slightly more common in women than in men.  The signs and symptoms of an unruptured cerebral aneurysm will partly depend on its size and rate of growth. For example, a small, unchanging aneurysm will generally produce no symptoms, whereas a larger aneurysm that is steadily growing may produce symptoms such as headache, numbness, loss of feeling in the face or problems with the eyes. Immediately after an aneurysm ruptures, an individual may experience such symptoms as a sudden and unusually severe headache, nausea, vision impairment, vomiting, and loss of consciousness.

MalaCards based summary : Cerebral Aneurysms, also known as cerebral aneurysm, is related to intracranial aneurysm and autosomal dominant polycystic kidney disease. An important gene associated with Cerebral Aneurysms is PKD1 (Polycystin 1, Transient Receptor Potential Channel Interacting), and among its related pathways/superpathways are Degradation of the extracellular matrix and Lung fibrosis. The drugs Hematinics and Epoetin alfa have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and heart, and related phenotype is neoplasm.

Related Diseases for Cerebral Aneurysms

Diseases related to Cerebral Aneurysms via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 127)
# Related Disease Score Top Affiliating Genes
1 intracranial aneurysm 32.3 ELN PKD1
2 autosomal dominant polycystic kidney disease 29.2 CCL2 PKD1
3 aneurysm 11.7
4 intracranial berry aneurysm 11.5
5 berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 11.1
6 loeys-dietz syndrome 4 11.0
7 cerebritis 11.0
8 pelvic inflammatory disease 10.2 CCL2 CTSB
9 familial cerebral saccular aneurysm 10.1
10 peripheral artery disease 10.1 CCL2 CST3
11 arteriovenous malformation 10.0
12 urinary system disease 10.0 CCL2 CST3
13 end stage renal failure 9.9 CST3 PKD1
14 mid-dermal elastolysis 9.9 ELANE ELN
15 elephantiasis 9.9 ELANE ELN
16 headache 9.9
17 erysipelas 9.9 ELANE ELN
18 chorioamnionitis 9.9 CCL2 ELANE
19 alpha-1-antitrypsin deficiency 9.9 ELANE ELN
20 autoinflammation, lipodystrophy, and dermatosis syndrome 9.9 CCL2 ELANE
21 pulmonary disease, chronic obstructive 9.9 ELANE ELN
22 idiopathic interstitial pneumonia 9.9 CCL2 ELANE
23 pulmonary emphysema 9.9 ELANE ELN
24 adult respiratory distress syndrome 9.9 ELANE ELN
25 thrombosis 9.9
26 hydrocephalus 9.9
27 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 9.9
28 cerebellofaciodental syndrome 9.9
29 arteriosclerosis 9.9 CCL2 ELN
30 respiratory system disease 9.9 CCL2 ELANE
31 periodontitis 9.8 CCL2 ELANE
32 aging 9.8
33 endotheliitis 9.8
34 takayasu arteritis 9.8
35 kawasaki disease 9.8 CCL2 ELANE
36 autosomal genetic disease 9.8 ELANE PKD1
37 vasculitis 9.8 CCL2 ELANE
38 thunderclap headache 9.8
39 carotid artery occlusion 9.8
40 fibromuscular dysplasia 9.8
41 ischemia 9.8
42 loeys-dietz syndrome 9.8
43 polycystic kidney disease 9.8
44 kidney disease 9.8
45 vascular disease 9.8 CCL2 CST3 ELN
46 chronic kidney failure 9.7 CST3 PKD1
47 wegener granulomatosis 9.7 ELANE ELN
48 acute pancreatitis 9.7 CTSB ELANE
49 metal allergy 9.7
50 alagille syndrome 1 9.7

Graphical network of the top 20 diseases related to Cerebral Aneurysms:



Diseases related to Cerebral Aneurysms

Symptoms & Phenotypes for Cerebral Aneurysms

MGI Mouse Phenotypes related to Cerebral Aneurysms:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 8.92 CST3 CTSB ELANE PKD1

Drugs & Therapeutics for Cerebral Aneurysms

Drugs for Cerebral Aneurysms (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 111)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Hematinics Phase 4
2 Epoetin alfa Phase 4 113427-24-0
3
Aspirin Approved, Vet_approved Phase 3,Phase 1 50-78-2 2244
4
Esmolol Approved Phase 3 81147-92-4, 103598-03-4 59768
5
Sevoflurane Approved, Vet_approved Phase 3,Phase 2 28523-86-6 5206
6
Propofol Approved, Investigational, Vet_approved Phase 3,Phase 2 2078-54-8 4943
7
Clopidogrel Approved Phase 3 120202-66-6, 113665-84-2 60606
8
Ticlopidine Approved Phase 3 55142-85-3 5472
9
Ticagrelor Approved Phase 3 274693-27-5 9871419
10 Analgesics Phase 3,Phase 1
11 Central Nervous System Depressants Phase 3,Phase 2,Phase 1
12 Neurotransmitter Agents Phase 3,Phase 2
13 Anesthetics Phase 3,Phase 2,Phase 1
14 Peripheral Nervous System Agents Phase 3,Phase 1
15 Fibrinolytic Agents Phase 3,Phase 2,Phase 1
16 Adrenergic Agents Phase 3
17 Adrenergic Antagonists Phase 3
18 Adrenergic beta-1 Receptor Antagonists Phase 3
19 Adrenergic beta-Antagonists Phase 3
20 Cyclooxygenase Inhibitors Phase 3,Phase 1
21 Analgesics, Non-Narcotic Phase 3,Phase 1
22 Anesthetics, General Phase 3,Phase 2
23 Anesthetics, Inhalation Phase 3,Phase 2
24 Anesthetics, Intravenous Phase 3,Phase 2
25 Hypnotics and Sedatives Phase 3,Phase 2
26 Platelet Aggregation Inhibitors Phase 3,Phase 2,Phase 1
27 Anti-Inflammatory Agents Phase 3,Phase 1
28 Anti-Inflammatory Agents, Non-Steroidal Phase 3,Phase 1
29 Antipyretics Phase 3,Phase 1
30 Antirheumatic Agents Phase 3,Phase 1
31 Cytochrome P-450 Enzyme Inhibitors Phase 3
32 Purinergic P2 Receptor Antagonists Phase 3
33 Purinergic P2Y Receptor Antagonists Phase 3
34
Benzocaine Approved, Investigational Phase 1, Phase 2 1994-09-7, 94-09-7 2337
35
Clevidipine Approved, Investigational Phase 2 167221-71-8
36
Nimodipine Approved, Investigational Phase 1, Phase 2 66085-59-4 4497
37
Heparin Approved, Investigational Phase 2 9005-49-6 46507594 772
38
Estradiol Approved, Investigational, Vet_approved Phase 2 50-28-2 5757
39
Midazolam Approved, Illicit Phase 2 59467-70-8 4192
40 tannic acid Approved, Nutraceutical Phase 1, Phase 2
41
Imidacloprid Vet_approved Phase 2 105827-78-9 86418
42 calcium channel blockers Phase 2,Phase 1
43 GABA Agents Phase 2
44 Tranquilizing Agents Phase 2
45 Pharmaceutical Solutions Phase 1, Phase 2
46 Psychotropic Drugs Phase 2
47 Calcium, Dietary Phase 2,Phase 1
48 Tin Fluorides Phase 2
49 Vasodilator Agents Phase 1, Phase 2
50 Antihypertensive Agents Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 79)

# Name Status NCT ID Phase Drugs
1 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
2 Treatment of Cranial Internal Carotid Artery Aneurysm With Willis Covered Stent and Coil Embolization Unknown status NCT01029938 Phase 4
3 TARGET Intracranial Aneurysm Coiling Registry Recruiting NCT01748903 Phase 4
4 HydroCoil Cerebral Aneurysm Treatment Trial Terminated NCT01195129 Phase 4
5 Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa Terminated NCT00626574 Phase 4 Epoetin alfa;Saline
6 Esmolol Infusion in Patients Undergoing Craniotomy Completed NCT02455440 Phase 3 Esmolol;Placebo;Propofol and sevoflurane
7 Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm Recruiting NCT02675205 Phase 3 Clopidogrel;Ticagrelor;aspirin
8 Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH) Unknown status NCT02011321 Phase 2 clevidipine
9 Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: Unknown status NCT02432157 Phase 1, Phase 2 HTS 3%;Standard fluid management
10 Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm Completed NCT00873015 Phase 2 Sodium nitrite;Saline
11 Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage Completed NCT01893190 Phase 1, Phase 2 Nimodipine;Nimodipine Microparticles
12 Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial Recruiting NCT01895881 Phase 2 Estradiol;Placebo
13 Sevoflurane in Subarachnoidal Haemorrhage Recruiting NCT02946437 Phase 2 Sevoflurane;Propofol;Midazolam
14 Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin Recruiting NCT02501434 Phase 2 Continuous Low-Dose IV Unfractionated Heparin Infusion
15 Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage Terminated NCT02176837 Phase 2 Sodium Nitrite
16 Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm Withdrawn NCT00871065 Phase 2 Sildenafil citrate
17 Sildenafil for Prevention of Cerebral Vasospasm Withdrawn NCT01091870 Phase 2 Placebo;Sildenafil Citrate, 25 mg, 3 times a day.;Sildenafil Citrate 50 mg, 3 times a day
18 Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Withdrawn NCT01878136 Phase 1, Phase 2 Tissue Plasminogen Activator
19 Aspirin Attenuates Inflammation in Human Cerebral Aneurysms Completed NCT01710072 Phase 1 aspirin
20 Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm Completed NCT02775318 Phase 1 Bupivacaine
21 Remote Ischemic Preconditioning in Subarachnoid Hemorrhage Completed NCT01158508 Phase 1
22 Screening Intracranial Aneurysms With Magnetic Resonance Angiography (MRA) in China Unknown status NCT00926172
23 Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms Unknown status NCT01702584
24 Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment Unknown status NCT02162654
25 Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms Unknown status NCT02345395
26 Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia Unknown status NCT01460563 Magnesium Sulfate;0.9% saline;0.9% saline
27 Registry for Study of Coils in Intracranial Aneurysms Unknown status NCT01000675
28 Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy Unknown status NCT02444832
29 Contrast-free Magnetic Resonance Angiography (MRA) at 3.0 T for Intracranial Aneurysm Detection Unknown status NCT01031147
30 Impact of Genetic Polymorphism on Propofol Requirement and Recovery for Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population Completed NCT02700126
31 Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Retrospective Study Concerning the Safety for Heart and Brain Completed NCT03281395
32 Surgical Theater's Surgery Rehearsal Platform Completed NCT02099318
33 Use of Classic LMA During Endovascular Therapy Completed NCT03288519
34 EEG Monitoring to Assess Emergence From Neuroanesthesia Completed NCT00443807
35 Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage Completed NCT00962546
36 Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing. Completed NCT00556309
37 Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage Completed NCT00614887
38 Genetic Analysis of Familial Brain Aneurysms Completed NCT00011856
39 Amnesia After Surgery for Anterior Communicating Aneurysm: High Resolution Magnetic Resonance (MR) Imaging Findings Completed NCT01919775
40 Cerebral Autoregulation and Vasospasm in Patients With TBI Completed NCT02351518
41 Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH) Completed NCT00692744
42 COMPLEX Post Market Surveillance Electronic Registry Completed NCT00663299
43 Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery Completed NCT01690364
44 Framing Eighteen Coils in Cerebral Aneurysms Trial Recruiting NCT01655784
45 Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1 Recruiting NCT03306823
46 Identification of Genetic Polymorphisms Related to Propofol Requirement and Recovery Through Genome-wide Association Study (GWAS) in Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population Recruiting NCT03087383
47 Preoperative Assessment and Individualized Operation Optimization of Acute Ruptured Cerebral Aneurysms Recruiting NCT02977520
48 Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients Recruiting NCT02507999
49 Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2 Recruiting NCT03306836 Heparin Sodium;Heparin Sodium
50 Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Study Concerning the Safety for Heart and Brain Recruiting NCT03184233

Search NIH Clinical Center for Cerebral Aneurysms

Genetic Tests for Cerebral Aneurysms

Genetic tests related to Cerebral Aneurysms:

# Genetic test Affiliating Genes
1 Cerebral Aneurysm 28

Anatomical Context for Cerebral Aneurysms

MalaCards organs/tissues related to Cerebral Aneurysms:

38
Brain, Eye, Heart, Pituitary, Whole Blood, Endothelial, Kidney

Publications for Cerebral Aneurysms

Articles related to Cerebral Aneurysms:

(show top 50) (show all 721)
# Title Authors Year
1
Endovascular treatment of cerebral aneurysm after renal transplantation in polycystic kidney disease. ( 29444616 )
2018
2
Cyclic Mechanical Stretch Induced Smooth Muscle Cell Changes in Cerebral Aneurysm Progress by Reducing Collagen Type IV and Collagen Type VI Levels. ( 29439246 )
2018
3
Hemodynamic characteristics of hyperplastic remodeling lesions in cerebral aneurysms. ( 29338059 )
2018
4
Secondary coiling after incomplete surgical clipping of cerebral aneurysms: a rescue strategy or a treatment option for complex cases? Institutional series and systematic review. ( 29417290 )
2018
5
Phase-contrast MRI versus numerical simulation to quantify hemodynamical changes in cerebral aneurysms after flow diverter treatment. ( 29304062 )
2018
6
In vitro measurement of the permeability of endovascular coils deployed in cerebral aneurysms. ( 29298858 )
2018
7
Thromboembolic complications during endovascular treatment of ruptured cerebral aneurysms. ( 29125027 )
2018
8
Effect of Local Coil Density on Blood Flow Stagnation in Densely Coiled Cerebral Aneurysms: A Computational Study Using a Cartesian Grid Method. ( 29383379 )
2018
9
Association of plasma D-dimer level with thromboembolic events after endovascular coil treatment of ruptured cerebral aneurysms. ( 29424648 )
2018
10
Stent-assisted coiling of cerebral aneurysms with the Neuroform Atlas stent. ( 29350091 )
2018
11
The dynamic natural history of cerebral aneurysms from cardiac myxomas: A review of the natural history of myxomatous aneurysms. ( 29383976 )
2018
12
Small Cerebral Aneurysms: Can We Identify Patients at Risk for Rupture? ( 28586919 )
2017
13
Circumferential Wall Enhancement on Magnetic Resonance Imaging is Useful to Identify Rupture Site in Patients with Multiple Cerebral Aneurysms. ( 28586440 )
2017
14
Cerebral Aneurysm Size and Distal Intracranial Hemodynamics: An Assessment of Flow and Pulsatility Index Using Quantitative Magnetic Resonance Angiography. ( 28945889 )
2017
15
Size is the Most Important Predictor of Aneurysm Rupture Among Multiple Cerebral Aneurysms: Post Hoc Subgroup Analysis of Unruptured Cerebral Aneurysm Study Japan. ( 28637201 )
2017
16
Transradial approach to treating endovascular cerebral aneurysms: Case series and technical note. ( 28584676 )
2017
17
Intraprocedural Rupture of Unruptured Cerebral Aneurysms During Coil Embolization: A Single-Center Experience. ( 28583450 )
2017
18
Monolateral pterional keyhole approaches to bilateral cerebral aneurysms: Anatomy and clinical application. ( 28927909 )
2017
19
Three-year experience with interventional neuroradiology for management of cerebral aneurysms at a single Australian centre. ( 28726260 )
2017
20
Complications associated with the use of flow-diverting devices for cerebral aneurysms: a systematic review and meta-analysis. ( 28565981 )
2017
21
Flow diversion of tandem cerebral aneurysms: a multi-institutional retrospective study. ( 28565979 )
2017
22
Macrophage Polarization in Cerebral Aneurysm: Perspectives and Potential Targets. ( 29445758 )
2017
23
Balloon-assisted coil embolization and large stent delivery for cerebral aneurysms with a new generation of dual lumen balloons (Copernic 2L). ( 28754807 )
2017
24
Update on flow diverters for the endovascular management of cerebral aneurysms. ( 28565980 )
2017
25
Occlusion status on magnetic resonance angiography is associated with risk of delayed ischemic events in cerebral aneurysms treated with stent-assisted coiling. ( 28826708 )
2017
26
Comparison of the Prevalence of Ruptured and Unruptured Cerebral Aneurysms in a Poor Urban Minority Population. ( 28623116 )
2017
27
Predictive Value of Motor Evoked Potential Monitoring during Surgery of Unruptured Anterior Circulation Cerebral Aneurysms. ( 29114276 )
2017
28
Introduction. The treatment of cerebral aneurysms: flow diversion and beyond. ( 28565982 )
2017
29
The Use of Ultrabrief Left Unilateral Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and Right-Sided Encephalomalacia and Stroke: A Case Report. ( 28767530 )
2017
30
The effectiveness of Penumbra 400 micro-coils in the embolization of large cerebral aneurysms. ( 28577823 )
2017
31
Proximal and Distal Occlusion of Complex Cerebral Aneurysms-Implications of Flow Modeling by Fluid-Structure Interaction Analysis. ( 29281095 )
2017
32
Endovascular embolization of branch-incorporated cerebral aneurysms. ( 29171364 )
2017
33
Computational fluid dynamics (CFD) using porous media modeling predicts recurrence after coiling of cerebral aneurysms. ( 29284057 )
2017
34
Hemodynamics of Focal Versus Global Growth of Small Cerebral Aneurysms. ( 29209882 )
2017
35
A Less Invasive Strategy for Ruptured Cerebral Aneurysms with Intracerebral Hematomas: Endovascular Coil Embolization Followed by Stereotactic Aspiration of Hematomas Using Urokinase. ( 29152466 )
2017
36
Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients. ( 28774792 )
2017
37
Relationship between patient safety indicator events and comprehensive stroke center volume status in the treatment of unruptured cerebral aneurysms. ( 29053070 )
2017
38
Successful Treatment With Electroconvulsive Therapy of a Patient With Bipolar Disorder and a 7-mm Cerebral Aneurysm. ( 28072662 )
2017
39
The Impact of the Endovascular Treatment of Cerebral Aneurysms on Headaches. ( 29095322 )
2017
40
Postprocedural, midterm, and long-term results of cerebral aneurysms treated with flow-diverter devices: 7-year experience at a single center. ( 28565988 )
2017
41
Deep neural network-based computer-assisted detection of cerebral aneurysms in MR angiography. ( 28836310 )
2017
42
Clinical evaluation of time-of-flight MR angiography with sparse undersampling and iterative reconstruction for cerebral aneurysms. ( 28796397 )
2017
43
Stent-assisted coiling of cerebral aneurysms: a single-center clinical and angiographic analysis. ( 29146831 )
2017
44
Trends in the treatment of cerebral aneurysms: Analysis of a hospital series. ( 29248208 )
2017
45
Endovascular treatment of cerebral aneurysms using the Woven EndoBridge technique in a single center: preliminary results. ( 27081907 )
2016
46
Patient-specific hemodynamics and stress-strain state of cerebral aneurysms. ( 27406681 )
2016
47
Prevalence and Characteristics of Unruptured Cerebral Aneurysms in Ischemic Stroke Patients. ( 27488981 )
2016
48
Determining the Presence of Thin-Walled Regions at High-Pressure Areas in Unruptured Cerebral Aneurysms by Using Computational Fluid Dynamics. ( 27028475 )
2016
49
Bypass Surgeries in the Treatment of Cerebral Aneurysms. ( 27637629 )
2016
50
Geographic Differences in Endovascular Treatment and Retreatment of Cerebral Aneurysms. ( 27390314 )
2016

Variations for Cerebral Aneurysms

ClinVar genetic disease variations for Cerebral Aneurysms:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 PKD1 NM_000296.3(PKD1): c.2079dupG (p.Pro694Alafs) duplication Pathogenic rs1057518923 GRCh37 Chromosome 16, 2165397: 2165397

Expression for Cerebral Aneurysms

Search GEO for disease gene expression data for Cerebral Aneurysms.

Pathways for Cerebral Aneurysms

Pathways related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.09 CTSB ELANE ELN
2 10.96 CCL2 ELN
3 10.55 ELANE ELN
4 9.98 CST3 CTSB

GO Terms for Cerebral Aneurysms

Cellular components related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.26 CCL2 CST3 CTSB ELANE
2 ficolin-1-rich granule lumen GO:1904813 9.16 CST3 CTSB
3 extracellular region GO:0005576 9.02 CCL2 CST3 CTSB ELANE ELN

Biological processes related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 animal organ morphogenesis GO:0009887 9.26 CCL2 ELN
2 extracellular matrix disassembly GO:0022617 9.16 ELANE ELN
3 neutrophil degranulation GO:0043312 9.13 CST3 CTSB ELANE
4 JAK-STAT cascade GO:0007259 8.62 CCL2 PKD1

Molecular functions related to Cerebral Aneurysms according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 8.62 CST3 ELANE

Sources for Cerebral Aneurysms

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....